查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1390737

2023-2028 年按产品类型、应用、配销通路和地区分類的鸦片类药物市场报告

Opioids Market Report by Product Type, Application, Distribution Channel, and Region 2023-2028
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3个工作天内

价格

抽象的

2022年全球鸦片类药物市场规模达212亿美元。展望未来， IMARC Group预计到2028年市场规模将达到256亿美元，2022-2028年复合年增长率（CAGR）为3.19%。慢性疼痛发病率的上升、老年人口的增加、癌症诊断的增加、医疗保健服务的改善、持续的研究和开发（R＆D）努力、消费者意识的提高以及有利的政府法规是推动市场的一些主要因素。

阿片类药物，也称为麻醉剂，是一类从罂粟植物中提取或在实验室合成的强效止痛药。这些物质作用于大脑和脊髓中的特定受体，主要是μ阿片受体，以减轻疼痛并引起欣快感。阿片类药物可分为两大类，包括处方阿片类药物（由医疗保健专业人员合法处方用于治疗剧烈疼痛）和非法阿片类药物（如海洛因），在没有医疗监督的情况下获取和使用。最常见的处方鸦片类药物包括羟考酮、氢可酮和芬太尼。

慢性疼痛（包括癌症相关疼痛和肌肉骨骼疾病）的盛行率不断上升，是需要开立鸦片类药物来治疗严重和持续性疼痛的关键驱动因素。除此之外，全球人口老化导致对鸦片类药物的需求不断增加，因为老年人经常经历与年龄相关的疾病和疼痛。此外，阿片类药物通常用于术后疼痛管理，因此全球外科手术的大幅增加正在增加对这些药物的需求，有助于市场扩张。除此之外，癌症诊断的增加，尤其是在发展中国家，正在推动阿片类药物的采用，以治疗与癌症相关的疼痛。此外，新兴市场医疗保健服务的改善导致阿片类药物的处方率更高，因为医疗保健提供者旨在满足疼痛管理需求，从而推动市场成长。

阿片类药物市场趋势/驱动因素：

慢性疼痛的盛行率不断增加

全球慢性疼痛盛行率不断上升，是阿片类药物市场成长的重要推手。慢性疼痛通常由关节炎、背部问题或神经性疾病等疾病引起，影响数百万人，因此需要有效的疼痛管理解决方案。阿片类药物因其缓解剧烈疼痛的功效而被医疗保健从业者广泛使用。同时，随着人口老化和预期寿命的延长，慢性疼痛的发生率也预计会增加，从而推动对鸦片类药物的需求。除此之外，对疼痛相关疾病的诊断和认识的提高正促使製药公司投资于研发（R＆D），以创造具有更高安全性的创新阿片类药物配方，进一步推动市场扩张。

人口老化

全球人口老化是阿片类药物市场的另一个关键驱动力。老年人经常患有与年龄相关的疾病，包括退化性关节疾病和癌症，导致慢性疼痛的情况增加，这反过来又刺激了对阿片类药物等疼痛管理方案的需求。儘管阿片类药物具有潜在的副作用和风险，但仍是该族群治疗中度至重度疼痛的常用处方选择。当其他疼痛管理策略被证明不足时，医疗保健提供者经常诉诸鸦片类药物。这种持续的需求增强了阿片类药物市场，因为製药公司开发了新的配方和给药方法来满足老龄化人口的特定需求。

全球癌症发生率上升

癌症诊断发生率的增加，特别是在新兴市场，导致对鸦片类药物的需求激增。癌症通常会出现剧烈疼痛作为常见症状，而鸦片类药物是癌症疼痛治疗的基石。随着全球癌症发生率持续上升，对有效止痛措施的需求也在增加，推动了鸦片类药物市场的成长。此外，医疗保健服务的改善正在导致癌症的早期诊断和治疗，因此需要使用鸦片类药物来控制疼痛。製药公司正在响应这一需求，开发专门的鸦片类药物製剂，旨在满足癌症患者独特的疼痛状况，进一步巩固阿片类药物在癌症治疗中的作用并推动市场扩张。

阿片类药物产业细分：

IMARC Group提供了全球阿片类药物市场报告各细分市场主要趋势的分析，以及 2023-2028 年全球、区域和国家层面的预测。我们的报告根据产品类型、应用和配销通路对市场进行了分类。

按产品类型划分：

可待因

芬太尼

美沙酮

羟考酮

吗啡

氢可酮

羟考酮在市场上占有最大份额

该报告根据产品类型对市场进行了详细的细分和分析。这包括可待因、芬太尼、美沙酮、羟考酮、吗啡和氢可酮。根据该报告，羟考酮代表了最大的部分。

羟考酮已成为阿片类药物市场的主导产品类型，因为它具有有效的止痛特性，使其能够非常有效地控制严重疼痛，包括术后疼痛和癌症相关疼痛。当其他疼痛治疗方法证明不足时，医生经常会开出羟考酮。此外，製药业在羟考酮缓释製剂的开发上投入了大量资金，以更少的给药间隔提供长期的疼痛缓解。这种便利因素促进了它的广泛使用。此外，羟考酮的多功能性允许多种给药途径，包括口服片剂、胶囊和静脉製剂，满足不同患者的需求，这反过来又推动了它的采用。此外，医疗保健提供者对羟考酮的功效和安全性的熟悉程度使其继续用作疼痛管理的主要选择，从而为市场成长创造了积极的前景。

按应用划分：

疼痛管理

咳嗽治疗

腹泻治疗

其他的

疼痛管理在市场上占有最大份额

报告还提供了基于应用程式的详细市场细分和分析。这包括疼痛管理、咳嗽治疗、腹泻治疗等。报告称，疼痛管理占最大的市场份额。

阿片类药物在医疗保健领域的基本作用以及人们对有效解决疼痛重要性的日益认识正在推动其在疼痛管理应用中的采用。疼痛是一个普遍而复杂的医疗问题，影响着全世界数百万人，阿片类药物被认为是治疗中度至重度疼痛的关键组成部分，特别是在急性和慢性疼痛、术后恢復和癌症相关疼痛中。由于老年人口的不断增长，与疼痛相关的疾病的普遍存在，以及癌症诊断发生率的上升，产生了对阿片类药物等有效止痛方法的持续需求，从而促进了市场增长。除此之外，医学界对改善患者生活品质的承诺导致人们越来越重视个人化疼痛管理计划，其中阿片类药物往往是一个关键要素，从而凸显了其在应用领域的主导地位。

按配销通路划分：

医院药房

零售药局

药局

网上商店

其他的

该报告根据配销通路对市场进行了详细的细分和分析。这包括医院药局、零售药局、药局、网路商店等。

骨关节炎和腰痛等慢性疼痛疾病盛行率的上升，导致零售药房和药局阿片类药物的处方和购买量激增，从而加强了市场成长。

此外，人们对疼痛管理的认识和倡导不断增强，促使医疗保健提供者开出阿片类药物治疗急性疼痛（通常透过医院药房获得），这正在影响市场的成长。

此外，网上购物的便利性和网上药局的激增使阿片类药物更容易获得，从而促进了产品需求的增加。全球阿片类药物市场的动力是需要严格的监管、加强教育工作以及所有分销管道负责任的处方实践，以在满足患者缓解疼痛的需求和保障公众健康之间取得平衡。

按地区划分：

北美洲

美国

加拿大

亚太

中国

日本

印度

韩国

澳洲

印尼

其他的

欧洲

德国

法国

英国

义大利

西班牙

俄罗斯

其他的

拉丁美洲

巴西

墨西哥

其他的

中东和非洲

北美表现出明显的主导地位，占据最大的鸦片类药物市场份额

市场研究报告还对所有主要区域市场进行了全面分析，其中包括北美（美国和加拿大）；亚太地区（中国、日本、印度、韩国、澳洲、印尼等）；欧洲（德国、法国、英国、义大利、西班牙、俄罗斯等）；拉丁美洲（巴西、墨西哥等）；以及中东和非洲。报告称，北美占据最大的市场份额。

由于多种因素，北美阿片类药物市场经历了大幅增长，包括背痛和骨关节炎等慢性疼痛疾病的高盛行率、人口老化以及阿片类药物在疼痛管理中的广泛使用。除此之外，医疗基础设施的改善和对疼痛管理选择的认识提高导致阿片类药物处方率上升，对市场成长产生了积极影响。此外，阿片类药物的流行以成瘾率和服药过量死亡率高为特征，透过增加使用丁丙诺啡和美沙酮等药物进行成瘾治疗和减少伤害，刺激了成长。专门的成瘾治疗中心和药房已经成为分销管道，满足了对这些药物的需求。此外，在更严格的指导方针和处方监控计划的影响下，不断发展的法规和处方实践正在影响市场的成长。

竞争格局：

领先的製药公司正在大力投资研发，以开发创新的鸦片类药物配方。这些努力的重点是创造具有改进的安全性、减少滥用可能性并增强疼痛管理功效的鸦片类药物。目标是为医疗保健专业人员提供更有效、更安全的治疗选择。此外，阿片类药物製造商正在密切监控并遵守与阿片类药物处方、分销和使用相关的不断变化的法规和指南。他们正在努力确保其产品符合最高的安全和品质标准，同时遵守严格的监管要求。所有这些努力正在塑造阿片类药物市场的未来。

该报告对市场竞争格局进行了全面分析。也提供了所有主要公司的详细资料。市场上的一些主要参与者包括：

勃林格殷格翰国际股份有限公司

希克马製药公司

马林克罗特公司

辉瑞公司

普渡製药公司

赛诺菲公司

太阳製药工业有限公司

梯瓦製药工业股份有限公司

最近的发展：

2021年6月，美国FDA受理并授予Purdue Pharma LP提交的盐酸纳美芬注射新药申请（NDA）优先审查资格。纳美芬注射是一种鸦片拮抗剂，旨在逆转鸦片类药物过量。

2022 年 11 月，Teva 宣布与 Rimidi 建立新型合作伙伴关係，以扩大呼吸数位健康平台的影响力。

本报告回答的关键问题：

  • 迄今为止，全球阿片类药物市场表现如何，未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的鸦片类药物市场？
  • 依产品类型分類的市场是怎么样的？
  • 阿片类药物市场中最具吸引力的产品类型是什么？
  • 基于应用的市场区隔是怎样的？
  • 阿片类药物市场上最具吸引力的应用是什么？
  • 基于配销通路的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 全球阿片类药物市场的竞争结构如何？
  • 谁是全球阿片类药物市场的主要参与者/公司？

本报告回答的关键问题：

  • 迄今为止，全球阿片类药物市场表现如何，未来几年将如何表现？
  • 全球阿片类药物市场的驱动因素、限制因素和机会是什么？
  • 每个驱动因素、限制因素和机会对全球鸦片类药物市场有何影响？
  • 主要区域市场有哪些？
  • 哪些国家代表了最具吸引力的鸦片类药物市场？
  • 依产品类型分類的市场是怎么样的？
  • 阿片类药物市场中最具吸引力的产品类型是什么？
  • 基于应用的市场区隔是怎样的？
  • 阿片类药物市场上最具吸引力的应用是什么？
  • 基于配销通路的市场区隔是什么？
  • 阿片类药物市场中最具吸引力的配销通路是什么？
  • 全球阿片类药物市场的竞争结构如何？
  • 谁是全球阿片类药物市场的主要参与者/公司？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 资料来源
    • 主要资源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球鸦片类药物市场

  • 市场概况
  • 市场业绩
  • COVID-19 的影响
  • 市场预测

第 6 章：依产品类型分類的市场区隔

  • 可待因
    • 市场走向
    • 市场预测
  • 芬太尼
    • 市场走向
    • 市场预测
  • 美沙酮
    • 市场走向
    • 市场预测
  • 羟考酮
    • 市场走向
    • 市场预测
  • 吗啡
    • 市场走向
    • 市场预测
  • 氢可酮
    • 市场走向
    • 市场预测

第 7 章：按应用分類的市场区隔

  • 疼痛管理
    • 市场走向
    • 市场预测
  • 咳嗽治疗
    • 市场走向
    • 市场预测
  • 腹泻治疗
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 8 章：按配销通路分類的市场区隔

  • 医院药房
    • 市场走向
    • 市场预测
  • 零售药局
    • 市场走向
    • 市场预测
  • 药局
    • 市场走向
    • 市场预测
  • 网上商店
    • 市场走向
    • 市场预测
  • 其他的
    • 市场走向
    • 市场预测

第 9 章：按地区分類的市场区隔

  • 北美洲
    • 美国
      • 市场走向
      • 市场预测
    • 加拿大
      • 市场走向
      • 市场预测
  • 亚太
    • 中国
      • 市场走向
      • 市场预测
    • 日本
      • 市场走向
      • 市场预测
    • 印度
      • 市场走向
      • 市场预测
    • 韩国
      • 市场走向
      • 市场预测
    • 澳洲
      • 市场走向
      • 市场预测
    • 印尼
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 欧洲
    • 德国
      • 市场走向
      • 市场预测
    • 法国
      • 市场走向
      • 市场预测
    • 英国
      • 市场走向
      • 市场预测
    • 义大利
      • 市场走向
      • 市场预测
    • 西班牙
      • 市场走向
      • 市场预测
    • 俄罗斯
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场走向
      • 市场预测
    • 墨西哥
      • 市场走向
      • 市场预测
    • 其他的
      • 市场走向
      • 市场预测
  • 中东和非洲
    • 市场走向
    • 按国家/地区分類的市场细分
    • 市场预测

第 10 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 11 章：价值链分析

第 12 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 13 章：价格分析

第14章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Boehringer Ingelheim International GmbH
    • Hikma Pharmaceuticals PLC
    • Mallinckrodt plc
    • Pfizer Inc.
    • Purdue Pharma LP
    • Sanofi SA
    • Sun Pharmaceutical Industries Ltd.
    • Teva Pharmaceutical Industries Ltd.
Product Code: SR112023A4559

Abstract

The global opioids market size reached US$ 21.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 25.6 Billion by 2028, exhibiting a growth rate (CAGR) of 3.19% during 2022-2028. The rising incidence of chronic pain conditions, expanding elderly population, increase in cancer diagnoses, improved access to healthcare services, ongoing research and development (R&D) efforts, escalating consumer awareness, and favorable government regulations are some of the major factors propelling the market.

Opioids, also known as narcotics, are a class of powerful pain-relieving medications derived from the opium poppy plant or synthesized in laboratories. These substances act on specific receptors in the brain and spinal cord, primarily the mu-opioid receptors, to alleviate pain and induce a sense of euphoria. Opioids can be classified into two main categories including, prescription opioids, which are legally prescribed by healthcare professionals to manage severe pain, and illicit opioids like heroin, which are obtained and used without medical supervision. The most common prescription opioids include oxycodone, hydrocodone, and fentanyl.

The expanding prevalence of chronic pain conditions, including cancer-related pain and musculoskeletal disorders, is a key driving factor necessitating the prescription of opioids for the management of severe and persistent pain. In addition to this, the global demographic shift towards an aging population is contributing to the increasing demand for opioids, as elderly individuals frequently experience age-related ailments and pain. Moreover, opioids are commonly used in post-operative pain management, consequently the significant surge in surgical procedures worldwide is boosting the demand for these medications, thereby aiding in market expansion. Besides this, the increase in cancer diagnoses, especially in developing countries, is fueling the adoption of opioids to manage cancer-related pain. Furthermore, improved access to healthcare services in emerging markets is leading to higher prescription rates for opioids as healthcare providers aim to address pain management needs, thus impelling the market growth.

Opioids Market Trends/Drivers:

Increasing prevalence of chronic pain

The escalating prevalence of chronic pain across the globe represents a significant growth-inducing driver of the opioids market. Chronic pain, often resulting from conditions such as arthritis, back problems, or neuropathic disorders, affects millions of individuals, necessitating effective pain management solutions. Opioids are widely prescribed by healthcare practitioners due to their potency in alleviating severe pain. Concurrent with this, as the population ages and life expectancy rises, the incidence of chronic pain is also expected to grow, propelling the demand for opioids. Besides this, improved diagnosis and awareness of pain-related disorders are prompting pharmaceutical companies to invest in research and development (R&D) to create innovative opioid formulations with enhanced safety profiles, further driving the market's expansion.

Aging population

The global demographic shift toward an aging population is another key driver of the opioids market. Elderly individuals often experience age-related ailments, including degenerative joint diseases and cancer, leading to increased instances of chronic pain, which, in turn, is fueling the demand for pain management options, such as opioids. Opioids, despite their potential side effects and risks, remain a commonly prescribed option for managing moderate to severe pain in this demographic. Healthcare providers often resort to opioids when other pain management strategies prove inadequate. This sustained demand has strengthened the opioid market, as pharmaceutical companies develop new formulations and delivery methods to cater to the specific needs of the aging population.

Rising cancer rates across the globe

The increasing incidence of cancer diagnoses, particularly in emerging markets, is contributing to the surging demand for opioids. Cancer often presents severe pain as a common symptom, and opioids are a cornerstone of cancer pain management. As cancer rates continue to rise globally, so does the demand for effective pain relief measures, fueling the opioid market's growth. Moreover, improved access to healthcare services is leading to earlier cancer diagnosis and treatment, necessitating the use of opioids for pain management. Pharmaceutical companies are responding to this demand by developing specialized opioid formulations designed to cater to the unique pain profiles of cancer patients, further solidifying the role of opioids in cancer care and driving market expansion.

Opioids Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global opioids market report, along with forecasts at the global, regional and country levels from 2023-2028. Our report has categorized the market based on product type, application and distribution channel.

Breakup by Product Type:

Codeine

Fentanyl

Methadone

Oxycodone

Morphine

Hydrocodone

Oxycodone holds the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the product type. This includes codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. According to the report, oxycodone represented the largest segment.

Oxycodone has emerged as a dominant product type in the opioids market for owing to its potent pain-relieving properties which make it highly effective in managing severe pain, including post-operative and cancer-related pain. Physicians often prescribe oxycodone when other pain management options prove insufficient. Moreover, the pharmaceutical industry has invested significantly in the development of extended-release formulations of oxycodone, offering prolonged pain relief with fewer dosing intervals. This convenience factor has contributed to its widespread use. Additionally, oxycodone's versatility allows for various administration routes, including oral tablets, capsules, and intravenous formulations, catering to diverse patient needs, which, in turn, is impelling its adoption. Moreover, the familiarity of healthcare providers with oxycodone's efficacy and safety profile has led to its continued use as a primary option for pain management, creating a positive outlook for market growth.

Breakup by Application:

Pain Management

Cough Treatment

Diarrhea Treatment

Others

Pain management holds the largest share in the market

A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes pain management, cough treatment, diarrhea treatment, and others. According to the report, pain management accounted for the largest market share.

Opioid's fundamental role in healthcare sector and the increasing recognition of the importance of effectively addressing pain is fueling its adoption in pain management applications. Pain is a pervasive and complex medical issue affecting millions of individuals worldwide, and opioids are considered a crucial component in managing moderate to severe pain, especially in acute and chronic pain conditions, post-surgical recovery, and cancer-related pain. The sheer prevalence of pain-related conditions owing to the growing geriatric population, and the rising incidence of cancer diagnoses have created a sustained demand for effective pain relief methods, such as opioids, thereby bolstering the market growth. In addition to this, the medical community's commitment to improving the quality of life for patients has led to a growing emphasis on personalized pain management plans, where opioids are often a key element, thus, underscoring its dominance in the application segment.

Breakup by Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Drug Stores

Online Stores

Others

The report has provided a detailed breakup and analysis of the market based on the distribution channel. This includes hospital pharmacies, retail pharmacies, drug stores, online stores, and others.

The rise in prevalence of chronic pain conditions, such as osteoarthritis and lower back pain, has led to a surge in the prescription and purchase of opioid medications through retail pharmacies and drug stores, strengthening the market growth.

Additionally, the growing awareness and advocacy for pain management prompting healthcare providers to prescribe opioids for acute pain, often obtained through hospital pharmacies is influencing the market's growth.

Furthermore, the convenience of online shopping and the proliferation of online pharmacies has made opioids more accessible, contributing to increased product demand. The global opioids market is driven by the need for stringent regulations, enhanced educational efforts, and responsible prescribing practices across all distribution channels to strike a balance between meeting patients' pain relief needs and safeguarding public health.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance, accounting for the largest opioids market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

The North American opioids market has experienced substantial growth due to several factors, including a high prevalence of chronic pain conditions, such as back pain and osteoarthritis, an aging population, and the widespread use of opioids in pain management. In addition to this, improved healthcare infrastructure and increased awareness of pain management options have led to higher opioid prescription rates, positively impacting the market growth. Moreover, the opioid epidemic, characterized by high rates of addiction and overdose deaths, has spurred growth through the increased use of medications such as buprenorphine and methadone for addiction treatment and harm reduction. Specialized addiction treatment centers and pharmacies have emerged as distribution channels, addressing the demand for these medications. Furthermore, evolving regulations and prescribing practices, influenced by stricter guidelines and prescription monitoring programs are influencing the market growth.

Competitive Landscape:

Leading pharmaceutical companies are investing heavily in R&D to develop innovative opioid formulations. These efforts focus on creating opioids with improved safety profiles, reduced potential for abuse, and enhanced efficacy in pain management. The goal is to provide healthcare professionals with more effective and safer treatment options. Moreover, opioid manufacturers are closely monitoring and complying with evolving regulations and guidelines related to opioid prescribing, distribution, and usage. They are working to ensure that their products meet the highest safety and quality standards while adhering to stringent regulatory requirements. All these efforts are shaping the future of the opioids market.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Boehringer Ingelheim International GmbH

Hikma Pharmaceuticals PLC

Mallinckrodt plc

Pfizer Inc.

Purdue Pharma L.P.

Sanofi S.A.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Recent Developments:

In June 2021, the U.S. FDA accepted and granted priority review designation to new drug application (NDA) submitted by Purdue Pharma L.P. for nalmefene hydrochloride injection. Nalmefene injectable is an opioid antagonist designed to reverse opioid overdose.

In November 2022, Teva announced a novel partnership with Rimidi to broaden the respiratory digital health platform's impact.

Key Questions Answered in This Report:

  • How has the global opioids market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global opioids market?
  • What is the impact of each driver, restraint, and opportunity on the global opioids market?
  • What are the key regional markets?
  • Which countries represent the most attractive opioids market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the opioids market?
  • What is the breakup of the market based on application?
  • Which is the most attractive application in the opioids market?
  • What is the breakup of the market based on distribution channel?
  • Which is the most attractive distribution channel in the opioids market?
  • What is the competitive structure of the global opioids market?
  • Who are the key players/companies in the global opioids market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Opioids Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Codeine
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Fentanyl
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Methadone
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Oxycodone
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Morphine
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hydrocodone
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Pain Management
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cough Treatment
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Diarrhea Treatment
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Hospital Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Retail Pharmacies
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Drug Stores
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Online Stores
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim International GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Hikma Pharmaceuticals PLC
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Mallinckrodt plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Pfizer Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Purdue Pharma L.P.
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Sanofi S.A.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Sun Pharmaceutical Industries Ltd.
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Teva Pharmaceutical Industries Ltd.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Opioids Market: Major Drivers and Challenges
  • Figure 2: Global: Opioids Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Opioids Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Opioids Market: Breakup by Product Type (in %), 2022
  • Figure 5: Global: Opioids Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Opioids Market: Breakup by Distribution Channel (in %), 2022
  • Figure 7: Global: Opioids Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Opioids (Codeine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Opioids (Codeine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Opioids (Fentanyl) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Opioids (Fentanyl) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Opioids (Methadone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Opioids (Methadone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Opioids (Oxycodone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Opioids (Oxycodone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Opioids (Morphine) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Opioids (Morphine) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Opioids (Hydrocodone) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Opioids (Hydrocodone) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Opioids (Pain Management) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Opioids (Pain Management) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Opioids (Cough Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Opioids (Cough Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Opioids (Diarrhea Treatment) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Opioids (Diarrhea Treatment) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Opioids (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Opioids (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Opioids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Opioids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Opioids (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Opioids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Opioids (Drug Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Opioids (Drug Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Opioids (Online Stores) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Opioids (Online Stores) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Opioids (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Opioids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: North America: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: North America: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: United States: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: United States: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Canada: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Canada: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Asia-Pacific: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Asia-Pacific: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: China: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: China: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Japan: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Japan: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: India: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: India: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: South Korea: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: South Korea: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Australia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Australia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Indonesia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Indonesia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Europe: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Europe: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: Germany: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: Germany: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: France: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: France: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: United Kingdom: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: United Kingdom: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Italy: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Italy: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Spain: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Spain: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Russia: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Russia: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Latin America: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Latin America: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Brazil: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Brazil: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Mexico: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Mexico: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Others: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Others: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Middle East and Africa: Opioids Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Middle East and Africa: Opioids Market: Breakup by Country (in %), 2022
  • Figure 86: Middle East and Africa: Opioids Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 87: Global: Opioids Industry: SWOT Analysis
  • Figure 88: Global: Opioids Industry: Value Chain Analysis
  • Figure 89: Global: Opioids Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Opioids Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Opioids Market Forecast: Breakup by Product Type (in Million US$), 2023-2028
  • Table 3: Global: Opioids Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Opioids Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
  • Table 5: Global: Opioids Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Opioids Market: Competitive Structure
  • Table 7: Global: Opioids Market: Key Players